ANAFAM is the National Association of Drug Manufacturers. Funded in 1945 by visionary business leaders, ANAFAM brings together Mexican pharmaceutical companies and ensures the quality of drugs meets international standards. Today, the association counts with 30 members which employ more than 16,500 people in the healthcare sector.
Contact Details
Av. Cuauhtemoc 1481-2 Piso
Col. Santa Cruz Atoyac, Del. Benito Juarez
CP 03310, México DF
MEXICO
Tel: +52 (55) 5601 3083
CP Maria del Socorro España Lomeli, executive director of the Mexican generics industry association ANAFAM, discusses the challenges with regard to the ‘new rules of the game’ in Mexico’s healthcare…
Socorro España Lomelí, executive director of Mexico’s National Association of Drug Manufacturers (ANAFAM), details her strategic priorities with regards to the promotion of the industry’s export strategy, the implementation of…
Healthcare is one of the next items on President Peña Nieto’s busy agenda. The objective: moving Mexico towards universal healthcare coverage. The initiative was started at the beginning of 2000…
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
Dr. José Angel Cordova Villalobos shares his experience as former Minister of Health and illustrates how the unification of today’s fragmented healthcare system is the only way to provide effective…
The opening of the Mexican Social Security Institute (IMSS) to clinical research is a unique opportunity for Mexico to step up on the international scenario for clinical trials. The CEO of…
Store brands are Perrigo’s core business. The vice president and managing director of the Mexican and Latin American affiliate discusses the company’s pioneer and early vision to bet on generics…
The executive director of the university spin-off UDIMEB explains the major achievements of the institution, her plans to convert it into a strategic partner to the pharmaceutical and biotechnology industry to…
The partner and leader of the healthcare practice for Mexico and Hispanic America shares his vision about how Mexico’s healthcare sector is converging to look at innovative ways to understand…
Healthcare should not be seen as an expenditure, but rather as an investment. Mexico’s former minister of health and current dean at the Harvard T.H. Chan School of Public Health…
Mr Carlos Jimenez of B. Braun Aesculap sat down with us and shared his personal beliefs on Mexico’s market potential for medical equipment, how the country can create more momentum…
Brothers Juan José and Andrés Aguirre Salazar of Grupo Bruluart talk about the company’s most important milestones and how they are institutionalizing the family business to prepare the firm for…
Clinical research and access are the name of the game. The Executive Director of the association bringing together the most important research-based pharmaceutical companies discusses how the association has stepped…
The genomic revolution represents a before and after in the field of medicine. Sistemas Genómicos has understood this back in 1998 and today is the largest private organization offering DNA…
See our Cookie Privacy Policy Here
